AP503
| Identifiers | |
|---|---|
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| Chemical and physical data | |
| Formula | C24H31N3O4 |
| Molar mass | 425.529 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
AP503 is a chemical compound which acts as an agonist at the androgen receptor GPR133. It increases muscle growth and bone density in animal models, and may have potential applications in the treatment of osteoporosis and sarcopenia in the elderly.[1][2]
See also
References
- ^ Yang Z, Ping YQ, Wang MW, Zhang C, Zhou SH, Xi YT, et al. (March 2025). "Identification, structure, and agonist design of an androgen membrane receptor". Cell. 188 (6): 1589–1604.e24. doi:10.1016/j.cell.2025.01.006. PMID 39884271.
- ^ Lehmann J, Lin H, Zhang Z, Wiermann M, Ricken AM, Brinkmann F, et al. (June 2025). "The mechanosensitive adhesion G protein-coupled receptor 133 (GPR133/ADGRD1) enhances bone formation". Signal Transduction and Targeted Therapy. 10 (1) 199. doi:10.1038/s41392-025-02291-y. PMC 12206920. PMID 40583059.